Lifecore Biomedical Inc (LFCR)
5.89
-0.23
(-3.76%)
USD |
NASDAQ |
May 15, 15:39
Lifecore Biomedical Cash and Short Term Investments (Quarterly): 19.09M for May 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2023 | 19.09M |
| February 28, 2023 | 2.95M |
| November 30, 2022 | 6.83M |
| August 31, 2022 | 4.222M |
| May 31, 2022 | 0.991M |
| February 28, 2022 | 1.854M |
| November 30, 2021 | 1.091M |
| August 31, 2021 | 1.447M |
| May 31, 2021 | 1.159M |
| February 28, 2021 | 2.248M |
| November 30, 2020 | 2.491M |
| August 31, 2020 | 0.589M |
| May 31, 2020 | 0.36M |
| February 29, 2020 | 2.607M |
| November 30, 2019 | 1.594M |
| August 31, 2019 | 1.99M |
| May 31, 2019 | 1.08M |
| February 28, 2019 | 1.722M |
| November 30, 2018 | 1.514M |
| August 31, 2018 | 1.359M |
| May 31, 2018 | 2.899M |
| February 28, 2018 | 7.65M |
| November 30, 2017 | 4.369M |
| August 31, 2017 | 8.191M |
| May 31, 2017 | 5.998M |
| Date | Value |
|---|---|
| February 28, 2017 | 12.73M |
| November 30, 2016 | 2.566M |
| August 31, 2016 | 8.626M |
| May 31, 2016 | 9.894M |
| February 29, 2016 | 8.214M |
| November 30, 2015 | 5.975M |
| August 31, 2015 | 7.103M |
| May 31, 2015 | 14.13M |
| February 28, 2015 | 15.70M |
| November 30, 2014 | 4.97M |
| August 31, 2014 | 8.529M |
| May 31, 2014 | 14.24M |
| February 28, 2014 | 12.99M |
| November 30, 2013 | 5.766M |
| August 31, 2013 | 10.19M |
| May 31, 2013 | 15.26M |
| February 28, 2013 | 13.73M |
| November 30, 2012 | 6.815M |
| August 31, 2012 | 10.80M |
| May 31, 2012 | 22.18M |
| February 29, 2012 | 37.63M |
| November 30, 2011 | 28.47M |
| August 31, 2011 | 39.35M |
| May 31, 2011 | 36.26M |
| February 28, 2011 | 38.44M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
0.36M
Minimum
May 2020
19.09M
Maximum
May 2023
3.094M
Average
1.854M
Median
Feb 2022
Cash and Short Term Investments (Quarterly) Benchmarks
| Aquestive Therapeutics Inc | 95.20M |
| SELLAS Life Sciences Group Inc | 2.53M |
| ADMA Biologics Inc | 45.32M |
| Relmada Therapeutics Inc | 83.61M |
| Jaguar Health Inc | 6.469M |